Vetnews | April 2026 18 « BACK TO CONTENTS Discussion In total, 38% of the dogs in the present study had antibodies against one or more of the pathogens investigated. IgG antibodies against tick-borne pathogens were detected in dogs from all regions in Norway, including northern regions where few established populations of I. ricinus have been confirmed [32]. I. ricinus is the predominant tick species in Norway [5, 6, 32] and is therefore the most likely source of pathogen exposure. However, exposure to other tick species cannot be excluded, nor can the possibility that some dogs acquired infection outside their county of residence, as travel history was not available for the included dogs. Furthermore, it has been demonstrated that infected dams may transfer maternal antibodies against B. burgdorferi s. l. to their pups [33], and vertical transmission of TBEV is suspected [34]. Hence, we cannot exclude the possibility that IgG-positive puppies acquired maternally derived antibodies or were infected vertically, rather than through tick exposure. Seroprevalence of IgG antibodies against tick-borne pathogens The overall seroprevalence of IgG antibodies against B. burgdorferi s. l. was 20%, ranging from 11 to 25%, depending on geographic region. Although no statistically significant differences between regions were seen, the highest seroprevalence was observed in Southern Norway, consistent with high tick population densities as well as previous reports of high prevalence of B. burgdorferi s. l. in questing ticks in this region [7]. This aligns with findings reported nearly three decades earlier from the same region, where the seroprevalence of B. burgdorferi s. l. in dogs, was 14% and 27%, respectively [35, 36]. In contrast, our data indicate a different trend in Northern Norway: A previous report published in 2012 found a canine seroprevalence of only 1.7% (2/120) in the northern region [37], whereas the present study found a higher seroprevalence of 11% (3/27). Although this may suggest a rise in exposure in northern regions, the small sample size in our study warrants cautious interpretation. Notably, the canine seroprevalence of B. burgdorferi s. l. in Nordic countries seems highly variable; 2.9% in Finland [38], 3.9% in Sweden [39], 16.1% in Denmark [40], and 20% in Norway. Also, a recent multicentre study reported an overall canine seroprevalence of 2.4% in Europe, but local results here also ranged widely, from 0 to 13.3% [41]. The seroprevalence is likely influenced by several factors, such as regional variation of tick abundance, environmental conditions affecting tick activity, intensity of local pathogen transmission, and levels of tick exposure in the sampled canine population. In addition, differences in test performance may influence seroprevalence estimates. When seroprevalence is interpreted in the context of the immunoassay’s reported sensitivity and specificity (both 100%), the positive results in our study likely represent true previous exposure to B. burgdorferi s. l. In the present study, the overall seroprevalence of IgG antibodies against TBEV was 19%, and seropositive dogs were seen in all regions. Regional seroprevalence ranged from 11% in Northern Norway to 28% in Southern Norway. The prevalence of TBEV in questing ticks collected in Norway is also highly variable, depending on region, ranging from 0 to 20.6% [6, 42]. Although several factors may influence the risk of infection, the varying endemicity of TBEV in different regions may partly explain the marked regional differences in seroprevalence observed in this study. Widely varying seroprevalence of TBEV in dogs is also seen across Europe, ranging from 0 to 40% depending on geographic location, endemicity, and study design [3, 44-47]. Previously, a study conducted in southern Norway found that 16% of dogs were seropositive [48]. The higher seroprevalence in the present study may partly be explained by differences in assay methodology, but could also reflect a true increase in tick abundance or infected ticks. Supporting this notion, there has been a general increase in reported human TBE cases in Norway over the past two decades [14]. The current study included a limited sample size from Central and Northern Norway, warranting cautious interpretation of the results. Furthermore, crossreaction with other flaviviruses cannot be excluded [43], and positive TBEV results should be interpreted with caution. Nevertheless, our findings indicate that dogs are at risk of acquiring tick-borne viral infection, and TBE should be considered among the differential diagnoses in dogs with neurological symptoms. The overall seroprevalence of IgG antibodies against A. phagocytophilum in dogs in the present study was 11%, with regional variations ranging from 0 to 23%. These findings fall within previously reported seroprevalence rates across Europe, which range from 0 to 43.3% [21, 38, 41, 49-52]. As for B. burgdorferi s. l. and TBEV, the wide variability may be caused by several factors. In Norway, the prevalence of A. phagocytophilum in questing ticks has also been shown to vary greatly between sites, from 0 to 17.5% [53-57], and may partly explain the regional differences in canine seroprevalence. Again, due to the limited sample size, the estimated seroprevalences in Northern and Central Norway should be interpreted with caution. Also, cross-reaction cannot be excluded, and Neoerlichia mikurensis is previously suggested to be the most likely agent cross-reacting with A. phagocytophilum in Norway [43]. Antibodies against tick-borne pathogens in domestic dogs in Norway..... <<< 17 Article Seroprevalence in dogs (2016-2023) (%) Human incidence (2024) (per 100,000 inhabitants Region Bbsl TBEV LB TBE Eastern Norway 18.2 19.7 6.5 1.0 Southern Norway 24.7 27.9 27.2 5.9 Western Norway 20.2 10.7 23.3 0 Central Norway 19.0 23.8 7.5 0 Northern Norway 11.1 11.1 1.0 0 Table 3 title: Canine seroprevalence and human Lyme borreliosis and tick-borne encephalitis incidence in Norway. Table 3 legends: Canine seroprevalence of Borrelia burgdorferi sensu lato (Bbsl) and tick-borne encephalitis virus (TBEV), in addition to human incidence (cases per 100,000 inhabitants) of Lyme borreliosis (LB) and tick-borne encephalitis (TBE) in the five regions of Norway.
RkJQdWJsaXNoZXIy OTc5MDU=